Article
FDA & OHRP Draft Guidance: Including Tissue Biopsies In Clinical Trials
The U.S. Food and Drug Administration (FDA), and the Office of Human Research protections (OHRP) released draft guidance titled, "Considerations for Including Tissue Biopsies in Clinical Trials."
Foley & Lardner